Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

balsalazide MeSH Supplementary Concept Data 2026


MeSH Supplementary
balsalazide
Unique ID
C038637
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C038637
Entry Term(s)
5-(carboxyethylcarbamoyl-4-phenylazo)salicylic acid
BX 661A
BX661A
Colazal
Colazide
balsalazide disodium
balsalazine
Pharm Action
Anti-Inflammatory Agents, Non-Steroidal
Gastrointestinal Agents
Registry Numbers
P80AL8J7ZP
Related Numbers
82101-18-6
CAS Type 1 Name
Benzoic acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, disodium salt
Previous Indexing
*AMINOSALICYLIC ACIDS (1983-2006)
Heading Mapped to
*Phenylhydrazines
*Mesalamine
Frequency
85
Note
a mesalamine 5-aminosalicylate prodrug; 99% of ingested drug remains intact through the stomach and is delivered to and activated in the colon; used for inflammatory bowel disease, ulcerative colitis and radiation-induced proctosigmoiditis but avoided in patients with known hypersensitivity reaction to salicylates or mesalamine; structure in first source
Source
Dig Dis Sci 1983;28(7):609
Indexing Information
Colitis, Ulcerative
Prodrugs
Inflammatory Bowel Diseases
Date Introduced
1983/08/11
Last Updated
2014/10/22
balsalazide Preferred
BX 661A Narrower
Colazal Narrower
balsalazide disodium Narrower
Colazide Narrower
balsalazine Narrower
page delivered in 0.011s